Stephens Investment Management Group LLC Has $45.76 Million Stock Position in Balchem Corporation (NASDAQ:BCPC)

Stephens Investment Management Group LLC lessened its holdings in Balchem Corporation (NASDAQ:BCPC - Free Report) by 1.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 275,687 shares of the basic materials company's stock after selling 3,240 shares during the quarter. Stephens Investment Management Group LLC owned approximately 0.85% of Balchem worth $45,764,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Covestor Ltd boosted its stake in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after purchasing an additional 76 shares during the last quarter. Federated Hermes Inc. bought a new position in shares of Balchem in the 4th quarter valued at about $33,000. Versant Capital Management Inc boosted its stake in shares of Balchem by 534.2% in the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock valued at $40,000 after purchasing an additional 203 shares during the last quarter. Huntington National Bank boosted its stake in shares of Balchem by 30.9% in the 4th quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock valued at $108,000 after purchasing an additional 156 shares during the last quarter. Finally, Atala Financial Inc bought a new position in shares of Balchem in the 4th quarter valued at about $123,000. Institutional investors own 87.91% of the company's stock.

Balchem Trading Down 2.2%

Shares of NASDAQ:BCPC traded down $3.49 during mid-day trading on Friday, reaching $158.44. The stock had a trading volume of 102,904 shares, compared to its average volume of 143,430. The firm has a market cap of $5.17 billion, a PE ratio of 38.00, a price-to-earnings-growth ratio of 3.42 and a beta of 0.89. The firm has a 50 day simple moving average of $163.82 and a two-hundred day simple moving average of $162.90. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18. Balchem Corporation has a twelve month low of $145.70 and a twelve month high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The firm had revenue of $250.52 million during the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. The business's revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.03 earnings per share. On average, research analysts predict that Balchem Corporation will post 4.64 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently weighed in on BCPC shares. HC Wainwright set a $180.00 price target on shares of Balchem and gave the company a "buy" rating in a research report on Monday, April 28th. Wall Street Zen downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.